Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Haploidentical Hematopoietic Stem Cell Transplantation”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableUnknownNCT03423706
What this trial is testing

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
CD19-chimeric Antigen Receptor T CellsRelapsed and/or Refractory Acute Lymphoblastic Leukemiathe Haploidentical Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Harbin Medical University 50
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Testing effectiveness (Phase 2)Looking for participantsNCT01861106
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Who this might be right for
GATA2ImmunodeficiencyMDS
National Cancer Institute (NCI) 144
Not applicableUnknownNCT05335226
What this trial is testing

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China 116
Not applicableLooking for participantsNCT06650553
What this trial is testing

Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

Who this might be right for
Aplastic Anemias
Shanxi Bethune Hospital 110
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Early research (Phase 1)Study completedNCT00458250
What this trial is testing

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Tehran University of Medical Sciences 10
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02646839
What this trial is testing

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes
Michael Pulsipher 50
Testing effectiveness (Phase 2)Looking for participantsNCT04356469
What this trial is testing

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

Who this might be right for
Hemoglobinopathy (Disorder)Severe Aplastic AnemiaBone Marrow Failure Syndrome
Johns Hopkins All Children's Hospital 17
Early research (Phase 1)Study completedNCT02167958
What this trial is testing

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Who this might be right for
LeukemiaMDSMyelofibrosis+1 more
Rafic Farah, MD 28
Testing effectiveness (Phase 2)Looking for participantsNCT03300492
What this trial is testing

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University Hospital, Basel, Switzerland 10
Not applicableUnknownNCT05814731
What this trial is testing

Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

Who this might be right for
Haploidentical Stem Cell TransplantationConditioning
First Affiliated Hospital Xi'an Jiaotong University 264
Not applicableUnknownNCT05629260
What this trial is testing

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Peking University People's Hospital 300
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

Who this might be right for
AMLMyelodysplastic SyndromesALL, Adult
TScan Therapeutics, Inc. 75
Testing effectiveness (Phase 2)WithdrawnNCT04024384
What this trial is testing

Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Trial

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)WithdrawnNCT03438344
What this trial is testing

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+9 more
City of Hope Medical Center
Post-approval studies (Phase 4)UnknownNCT03190733
What this trial is testing

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Who this might be right for
Chronic Graft-versus-host-diseaseLeukemia Relapse
Zhujiang Hospital 192
Testing effectiveness (Phase 2)Study completedNCT03236220
What this trial is testing

Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital 35
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Load More Results